Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly
17. juni 2026 opdateret af: Ali Mohamed Ali ismail, Cairo University
Addtion of Hyperbaric Oxygen to Programmed Physical Activity in Aromatse Inhibtors-linked Musckoloskeletal Pain in Breast Cancer Patients
patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains.
Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
forty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake were assigned to two groups, group I and group II. the groups received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) but group II additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
40
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Ali MA Ismail, lecturer
- Telefonnummer: 01005154209
- E-mail: ali.mohamed@pt.cu.edu.eg
Undersøgelse Kontakt Backup
- Navn: ali moahmed, lecturer
- Telefonnummer: 01031321109
- E-mail: fatmaraed1994@gmail.com
Studiesteder
-
-
Giza Governorate
-
Dokki, Giza Governorate, Egypten, 11432
- Rekruttering
- Cairo University
-
Kontakt:
- ali AM Ismail, lecturer
- Telefonnummer: +201005154209
- E-mail: ali.mohamed@pt.cu.edu.eg
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- braest cancer survivors
- patients receiving aramatase inhibitor drugs
- patients with musckolskeletal pains
Exclusion Criteria:
- cardiac patients
- respiratory patients
- renal patients
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: group number 1
Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) and additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.
|
Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) and additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.
|
|
Aktiv komparator: group number 2
Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month)
|
Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly for 2 month).
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
visual analogue scale
Tidsramme: it will be measured after 2 months
|
it self asessmant of pain level
|
it will be measured after 2 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
worst pain
Tidsramme: it will be measured after 2 months
|
it is a subscore of brief pain inventory
|
it will be measured after 2 months
|
|
pain severity
Tidsramme: it will be measured after 2 months
|
it is a subscore of brief pain inventory
|
it will be measured after 2 months
|
|
pain related interference
Tidsramme: it will be measured after 2 months
|
it is a subscore of brief pain inventory
|
it will be measured after 2 months
|
|
pain score
Tidsramme: it will be measured after 2 months
|
it is a sub score of Western Ontario and McMaster Universities Osteoarthritis
|
it will be measured after 2 months
|
|
stifness score
Tidsramme: it will be measured after 2 months
|
it is a sub score of Western Ontario and McMaster Universities Osteoarthritis
|
it will be measured after 2 months
|
|
fucntion score
Tidsramme: it will be measured after 2 months
|
it is a sub score of Western Ontario and McMaster Universities Osteoarthritis
|
it will be measured after 2 months
|
|
total score of Western Ontario and McMaster Universities Osteoarthritis
Tidsramme: it will be measured after 2 months
|
it is usualy used in patients with arthritic pains
|
it will be measured after 2 months
|
|
Disabilities of the Arm, Shoulder and Hand questionnaire
Tidsramme: it will be measured after 2 months
|
the short form of it used in patients with arthritic pains
|
it will be measured after 2 months
|
|
fatigue severity scale
Tidsramme: it will be measured after 2 months
|
it is used to assess fatigue
|
it will be measured after 2 months
|
|
Short Physical Performance Battery
Tidsramme: it will be measured after 2 months
|
total score used to assess physical performance
|
it will be measured after 2 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Ali MA Ismail, lecturer, Cairo University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
7. maj 2026
Primær færdiggørelse (Anslået)
1. september 2026
Studieafslutning (Anslået)
1. september 2026
Datoer for studieregistrering
Først indsendt
17. juni 2026
Først indsendt, der opfyldte QC-kriterier
17. juni 2026
Først opslået (Faktiske)
23. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
23. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
17. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB000-14233-82
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .